Institute of Cardiovascular Sciences
Widely regarded as one of the preeminent basic cardiovascular research programs in the world, St. Boniface Hospital Research’s Institute of Cardiovascular Sciences, led by Dr. Lorrie Kirshenbaum, is a leading force in the fight against heart disease at the cellular and molecular levels.
Duhamel appointed Associate Dean
Congratulations to Dr. Todd Duhamel, who was recently appointed as Associate Dean (Health Sciences), Faculty of Graduate Studies, effective September 1, 2021. Dr. Todd Duhamel is a Principal Investigator within the Institute of Cardiovascular Sciences, St. Boniface...
Yan selected as 2021 Paul Dudley White (PDW) International Scholar
Weiang Yan, PhD student, was recently recognized by the AHA as part of its upcoming Basic Cardiovascular Science (BCVS) Scientific Sessions 2021 Conference, whereby the primary author of the highest ranked accepted abstract from each country is designated as a PDW...
Araujo and Manson named 2021 Vanier Scholars
Congratulations to Daniel Schwade Araujo and Anne Manson, PhD students here at St. Boniface Hospital Research, who were both named 2021 Vanier Scholars. Araujo, studying at the Faculty of Kinesiology and Recreation Management, will undertake a PhD in Applied Health...
St. Boniface Investigators attract over $300,000 in NSERC funding
The Natural Sciences and Engineering Research Council (NSERC) recently awarded two significant grants to support the work of Dhingra and Moghadasian respectively. Dr. Mohammed Moghadasian, Principal Investigator of the Pathology Research Laboratory, Canadian Centre...
Molecular Cardiology Program publishes exciting finding on why SKI acts as a ‘scaffold’ inhibiting fibroblast activation.
On behalf of the Molecular Cardiology Program under the direction of Dr. Ian Dixon, we are very pleased to announce the exciting publishing news of their paper, “SKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation”. The paper...
Dhingra Lab Publishes Work on Next Generation Biomaterial in High Impact Nanotechnology Journal
Data indicates potential game-changer, extending implantable medical device battery-life up to 20 years. Researchers in the Cardiac Regeneration and Tissue Engineering Program at St. Boniface Hospital Research have synthesized a next-generation bio-compatible...